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These results were presented in part at the 32nd World Congress of the International Federation of Biomedical Laboratory Science, Kobe, 2016, and the study received the Good Poster Award.

1. INTRODUCTION {#dc23844-sec-0005}
===============

For the intraoperative consultation of ovarian tumors, obtaining a precise evaluation of the gross morphology is important. Chen et al. described the relation between gross morphology and various ovarian diseases.[1](#dc23844-bib-0001){ref-type="ref"} Even if the gross morphology is precisely evaluated in ovarian tumors, the intraoperative diagnosis depends on the histological evaluation of frozen sections.[1](#dc23844-bib-0001){ref-type="ref"}, [2](#dc23844-bib-0002){ref-type="ref"} However, the histological diagnosis of frozen sections of large ovarian tumors is frequently difficult because of the limited number of tumor samples. In contrast, diagnosis using imprint cytology, in which samples are obtained from wide areas of tumors, is useful for the intraoperative consultation of ovarian tumors. Thus, in an intraoperative consultation, the application of both imprint cytology and histological diagnosis of frozen sections has been recommended for ovarian tumors.[3](#dc23844-bib-0003){ref-type="ref"}, [4](#dc23844-bib-0004){ref-type="ref"}, [5](#dc23844-bib-0005){ref-type="ref"}

Although the application of imprint or scrape cytology for the intraoperative consultation of ovarian tumors has been reported,[3](#dc23844-bib-0003){ref-type="ref"}, [4](#dc23844-bib-0004){ref-type="ref"}, [5](#dc23844-bib-0005){ref-type="ref"}, [6](#dc23844-bib-0006){ref-type="ref"}, [7](#dc23844-bib-0007){ref-type="ref"}, [8](#dc23844-bib-0008){ref-type="ref"}, [9](#dc23844-bib-0009){ref-type="ref"}, [10](#dc23844-bib-0010){ref-type="ref"}, [11](#dc23844-bib-0011){ref-type="ref"} only the study of Michael et al. compared the intraoperative consultation of cytology and frozen sections of ovarian tumors.[6](#dc23844-bib-0006){ref-type="ref"} In their study, the diagnostic accuracy of cytology was better than that of frozen sections, but a comparison of the cytology and frozen sections in each of the examined cases was not performed. Thus, in the present study, a detailed comparison of the cytology and frozen sections in the intraoperative consultation of ovarian tumors was performed, and the useful aspects of cytology in the intraoperative consultation of ovarian tumors were clearly defined.

2. MATERIALS AND METHODS {#dc23844-sec-0006}
========================

Among the patients undergoing surgery for an ovarian tumor between June 1, 2013, and September 30, 2015, at Juntendo University Nerima Hospital, 55 patients who had both imprint cytology and histological diagnoses of frozen sections were selected. Samples for imprint cytology were obtained from several parts of the tumors presenting different gross morphology, and the samples underwent to Papanicolaou staining. Samples for frozen sections were obtained from a few areas of the tumors and processed in a conventional manner to produce frozen sections, and the tissue sections were stained with hematoxylin‐eosin (H.E.).

Surgical resection tissues fixed in 10% formalin were routinely processed for light microscopy, and the histological diagnosis of the tissue sections was made by H.E. staining. When the histological diagnosis was difficult, immunostaining was also performed. The histological diagnosis of an ovarian tumor was established according to a newly published WHO classification.[12](#dc23844-bib-0012){ref-type="ref"} The classification of mixed carcinoma in the ovary was not included in the WHO classification, but a previously published study of the imprint cytology of ovarian tumors described mixed carcinoma of the ovary; therefore, in the present study, the classification of mixed carcinoma was adopted.

The histological diagnoses of the surgical resections were divided into a benign group (16 cases), a borderline group (6 cases), and a malignant group (33 cases). The benign group consisted of fibrothecoma (5 cases), mucinous cystadenoma (4 cases), mature teratoma (2 cases), struma ovarii (2 cases), endometriotic cyst (1 case), serous cystadenofibroma (1 case), and fibrothecoma plus serous cystadenoma (1 case). The cases belonging to the malignant group were diagnosed as various types of carcinoma, including serous carcinoma (5 cases), mucinous carcinoma (3 cases), endometrioid carcinoma (7 cases), clear cell carcinoma (10 cases), mixed carcinoma (6 cases), undifferentiated carcinoma (1 case), and metastatic adenocarcinoma (1 case). Based on the histological diagnosis of the surgical resections, the accuracy of intraoperative imprint cytology was evaluated, and the accuracy of imprint cytology and frozen sections was compared.

The present study is a retrospective study. The surgeons obtained written informed consent for performing the cytological and histological examinations from all patients when they underwent operation. The approval for assessing the patient demographic data was not obtained from the patients, therefore personal information from each of the patients was not included in the manuscript. The informed consent form and procedure were approved by the Research Ethics Committee of Juntendo University Nerima Hospital.

3. RESULTS {#dc23844-sec-0007}
==========

The benignity and malignancy were diagnosed entirely by both imprint cytology and frozen tissue sections of the benign and malignant groups (Table [1](#dc23844-tbl-0001){ref-type="table-wrap"}). For the borderline group, the diagnostic accuracy of imprint cytology was very low (1/6: 16.6%) compared with that of frozen sections (4/6: 66.6%) (Table [1](#dc23844-tbl-0001){ref-type="table-wrap"}). In the 3 cases with seromucinous borderline tumors, an accurate diagnosis was not achieved by imprint cytology (Table [2](#dc23844-tbl-0002){ref-type="table-wrap"}), with under‐diagnoses in 2 cases (Case Bord3 and Bord4) and an over‐diagnosis in 1 case (Case Bord5). The diagnostic accuracy including benign, borderline, and malignant groups was 90.9% (50/55) for imprint cytology and 96.3% (53/55) for frozen sections.

###### 

Intraoperative accuracy of imprint cytology and frozen sections in 55 cases of benign, borderline and malignant tumors diagnosed by surgical resection tissues

  Group (No. of cases)    Diagnosis of imprint cytology (No. of cases)   Histological diagnosis of frozen sections (No. of cases)
  ----------------------- ---------------------------------------------- ----------------------------------------------------------
  Benignity (16 cases)    Benignity (16 cases)                           Benignity (16 cases)
  Borderline (6 cases)    Benignity (3 cases)                            Benignity (1 case)
                          Borderline (1 case)                            Borderline (4 cases)
                          Malignancy (2 cases)                           Malignancy (1 case)
  Malignancy (33 cases)   Malignancy (33 cases)                          Malignancy (33 cases)

###### 

Comparison among diagnosis of intraoperative imprint cytology, intraoperative frozen sections, and surgical resection tissues in 55 cases of ovarian tumors

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case No.   Diagnosis of imprint cytology              Histological diagnosis of frozen sections   Histological diagnosis of surgical resections
  ---------- ------------------------------------------ ------------------------------------------- ------------------------------------------------------------------------------
  B1         Fibroma                                    Thecoma                                     Fibrothecoma

  B2         Fibroma                                    Thecoma                                     Fibrothecoma

  B3         Thecoma                                    Fibrothecoma                                Fibrothecoma

  B4         Fibroma                                    Fibroma                                     Fibrothecoma

  B5         Thecoma                                    Fibrothecoma                                Fibrothecoma

  B6         Thecoma                                    Fibrothecoma +\                             Fibrothecoma +serous cystadenoma
                                                        Serous cystadenoma                          

  B7         Mucinous cystadenoma                       Mucinous cystadenoma                        Mucinous cystadenoma

  B8         Mucinous cystadenoma                       Mucinous cystadenoma                        Mucinous cystadenoma

  B9         Mucinous cystadenoma                       Seromucinous cystadenoma                    Mucinous cystadenoma

  B10        Benign mucinous tumor                      Mucinous cystadenoma                        Mucinous cystadenoma

  B11        Benign serous tumor                        Serous cystadenofibroma                     Serous cystadenofibroma

  B12        Mature teratoma                            Mature teratoma                             Mature teratoma

  B13        Mature teratoma                            Mature teratoma                             Mature teratoma

  B14        Cystic lesion                              Endometriotic cyst                          Endometriotic cyst

  B15        Struma ovarii                              Struma ovarii                               Struma ovarii

  B16        Struma ovarii                              Struma ovarii                               Struma ovarii

  Bord1      Serous borderline tumor                    Serous borderline tumor                     Serous borderline tumor

  Bord2      Mucinous cystadenoma                       Mucinous borderline\                        Mucinous borderline tumor
                                                        tumor                                       

  Bord3      Adenofibroma                               Mucinous cystadenoma                        Seromucinous borderline\
                                                                                                    Tumor

  Bord4      Benign serous tumor                        Seromucinous borderline tumor               Seromucinous borderline tumor

  Bord5      Endometrioid carcinoma                     Mucinous carcinoma                          Seromucinous borderlime\
                                                                                                    tumor

  Bord6      Clear cell carcinoma +mucinous carcinoma   Seromucinous borderline tumor               Endometroid borderline tumor ≫ clear cell and seromucinous borderline tumors

  SC1        Serous carcinoma                           Serous carcinoma                            Serous carcinoma

  SC2        Serous carcinoma +mucinous carcinoma       Serous carcinoma                            Serous carcinoma

  SC3        Serous carcinoma                           Endometrioid carcinoma                      Serous carcinoma

  SC4        Serous carcinoma +endometrioid carcinoma   Serous carcinoma +endometrioid carcinoma    Serous carcinoma

  SC5        Serous carcinoma                           Serous carcinoma                            Serous carcinoma

  EC1        Endometrioid carcinoma                     Endometrioid carcinoma                      Endometrioid carcinoma

  EC2        Endometrioid carcinoma                     Endometrioid carcinoma                      Endometrioid carcinoma

  EC3        Endometrioid carcinoma                     Endometrioid carcinoma                      Endometrioid carcinoma

  EC4        Endometrioid carcinoma                     Endometrioid carcinoma                      Endometrioid carcinoma

  EC5        Endometrioid carcinoma                     Endometrioid carcinoma                      Endometrioid carcinoma

  EC6        Endometrioid carcinoma                     Endometrioid carcinoma                      Endometrioid carcinoma

  EC7        Serous carcinoma                           Poorly differentiated\                      Endometrioid carcinoma
                                                        carcinoma                                   

  MC1        Endometrioid carcinoma                     Mucinous carcinoma                          Mucinous carcinoma

  MC2        Mucinous carcinoma                         Mucinous carcinoma                          Mucinous carcinoma

  MC3        Mucinous carcinoma                         Mucinous carcinoma                          Mucinous carcinoma

  CCC1       Clear cell carcinoma                       Clear cell carcinoma                        Clear cell carcinoma

  CCC2       Clear cell carcinoma                       Clear cell carcinoma                        Clear cell carcinoma

  CCC3       Clear cell carcinoma                       Clear cell carcinoma                        Clear cell carcinoma

  CCC4       Clear cell carcinoma                       Clear cell carcinoma                        Clear cell carcinoma

  CCC5       Clear cell carcinoma                       Clear cell carcinoma                        Clear cell carcinoma

  CCC6       Clear cell carcinoma                       Clear cell carcinoma                        Clear cell carcinoma

  CCC7       Clear cell carcinoma                       Clear cell carcinoma                        Clear cell carcinoma

  CCC8       Clear cell carcinoma                       Clear cell carcinoma                        Clear cell carcinoma

  CCC9       Clear cell carcinoma                       Serous carcinoma                            Clear cell carcinoma

  CCC10      Clear cell carcinoma                       Metastatic adenocarcinoma                   Clear cell carcinoma

  Mix1       Mixed carcinoma:\                          Endometrioid carcinoma                      Mixed carcinoma:\
             Endometrioid \> Clear                                                                  Endometrioid \> Clear

  Mix2       Mixed carcinoma:\                          Endometrioid carcinoma                      Mixed carcinoma\
             Serous \> Endometrioid                                                                 Serous \> Endometrioid

  Mix3       Clear cell carcinoma                       Endometrioid carcinoma                      Mixed carcinoma:\
                                                                                                    Clear \> Serous \>\
                                                                                                    Endometrioid

  Mix4       Mixed carcinoma:\                          Endometrioid carcinoma                      Mixed carcinoma:\
             Endometrioid and Serous                                                                Endometrioid and Clear

  Mix5       Mixed carcinoma:\                          Endometrioid carcinoma                      Mixed carcinoma:\
             Endometrioid and Serous                                                                Serous \> Endometrioid

  Mix6       Mixed carcinoma:\                          Mixed carcinoma:\                           Mixed carcinoma:\
             Endometrioid and Clear                     Endometrioid and Clear                      Endometrioid \> Clear

  Other1     Poorly diff. carcinoma                     Serous carcinoma                            Undiff. Carcinoma

  Other2     Metastatic carcinoma                       Metastatic carcinoma                        Metastatic carcinoma
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Concerning the diagnosis of the different types of carcinoma, serous carcinoma (Table [2](#dc23844-tbl-0002){ref-type="table-wrap"}, Figure [1](#dc23844-fig-0001){ref-type="fig"}) and endometrioid carcinoma (Table [2](#dc23844-tbl-0002){ref-type="table-wrap"}, Figure [2](#dc23844-fig-0002){ref-type="fig"}) were diagnosed with the same accuracy using imprint cytology and frozen sections: serous carcinoma, imprint cytology (3/5, 60%) compared to frozen sections (3/5, 60%) and endometrioid carcinoma, imprint cytology (6/7, 86%) compared to frozen sections (6/7, 86%). In mucinous carcinoma, the diagnostic accuracy of frozen sections (3/3, 100%) was greater than that of imprint cytology (2/3, 66.6%) (Table [2](#dc23844-tbl-0002){ref-type="table-wrap"}, Figure [3](#dc23844-fig-0003){ref-type="fig"}). In contrast, the diagnostic accuracy of imprint cytology was greater than that of frozen sections for clear cell carcinoma (Table [2](#dc23844-tbl-0002){ref-type="table-wrap"}, Figure [4](#dc23844-fig-0004){ref-type="fig"}: imprint cytology, 10/10, 100%; frozen sections, 8/10, 80%) and mixed carcinoma (Table [2](#dc23844-tbl-0002){ref-type="table-wrap"}: imprint cytology, 4/6, 66.6%; frozen sections, 1/6, 16.6%). For the overall accuracy of the diagnoses of the abovementioned carcinomas, imprint cytology (25/31, 80.6%) was more accurate than frozen sections (21/31, 67.7%).

![Imprint cytology of serous carcinoma (Case SC1). Note the papillary structure of high cellular epithelium (**A**), cuboidal epithelial cells with moderate to severe cellular atypia (**B**) and psammoma bodies (**C**). (Papanicolaou stain; **A**, ×100, **B**, ×200, **C**, ×400) \[Color figure can be viewed at [wileyonlinelibrary.com](http://wileyonlinelibrary.com)\]](DC-46-28-g001){#dc23844-fig-0001}

![Imprint cytology of endometrioid carcinoma (Case EC1). Note the thick‐layered cell clusters consisting of high cellular epithelial cells and a necrotic background (**A**), as well as squamous metaplasia (indicated by an arrow) and marked cellular atypia (**B**). (Papanicolaou stain; **A**, ×100, **B**, ×400) \[Color figure can be viewed at [wileyonlinelibrary.com](http://wileyonlinelibrary.com)\]](DC-46-28-g002){#dc23844-fig-0002}

![Imprint cytology of mucinous carcinoma (Case MC2). Note the thick‐layered cell clusters consisting of columnar epithelial cells with moderate to severe cellular atypia (**A**) and mucinous pooling in the cytoplasm of atypical epithelial cells (**B**). (Papanicolaou stain; **A**, ×200, **B**, ×400) \[Color figure can be viewed at [wileyonlinelibrary.com](http://wileyonlinelibrary.com)\]](DC-46-28-g003){#dc23844-fig-0003}

![Imprint cytology and histology of clear cell carcinoma (Case CCC1). Note the sheet‐like arrangement of epithelial cells with clear cytoplasm and moderate cellular atypia (**A and B**) and stromal hyalinization (**C,** indicated by an arrow) in imprint cytology. (Papanicolaou stain; **A**, ×200, **B**, ×400, **C**, ×400). **(D)** Solid sheets composed of cells with clear cytoplasm surrounded by stromal hyalinization histologically. (HE stain, ×400) \[Color figure can be viewed at [wileyonlinelibrary.com](http://wileyonlinelibrary.com)\]](DC-46-28-g004){#dc23844-fig-0004}

4. DISCUSSION {#dc23844-sec-0008}
=============

Concerning the use of imprint cytology in intraoperative consultation of ovarian epithelial tumors, Nagai et al. examined the imprint cytology of 354 consecutive surgical specimens, and reported that the accuracy of intraoperative imprint cytology was 87.1% for benign, 30% for borderline, and 83.6% for malignant tumors.[9](#dc23844-bib-0009){ref-type="ref"} They concluded that imprint cytology was significantly useful for the diagnosis of malignancy based on the operating characteristic curves.[9](#dc23844-bib-0009){ref-type="ref"} Thereafter, Khunamornpong and Siriaunkgul examined the scrape cytology of 131 cases of ovarian non‐neoplastic lesions and tumors, and their accuracy was 95% for benign, 47% for borderline, and 98% for malignant tumors.[10](#dc23844-bib-0010){ref-type="ref"} No misdiagnosis was observed in the benign and malignant categories.[10](#dc23844-bib-0010){ref-type="ref"} The present study obtained results similar to those of the abovementioned studies; both benign lesions and malignant tumors were accurately diagnosed by imprint cytology in intraoperative consultation. In addition, statistical analyses were not conducted in the present study due to our experiences in previously published studies that included statistical analyses,[13](#dc23844-bib-0013){ref-type="ref"}, [14](#dc23844-bib-0014){ref-type="ref"}, [15](#dc23844-bib-0015){ref-type="ref"} because all patients in both the benign and malignant groups were diagnosed by imprint cytology and frozen sections.

The intraoperative accuracy of imprint cytology in diagnosing borderline tumors was low in the present study. The intraoperative diagnosis of borderline tumors by cytology is difficult because of the admixture of benign and borderline areas in the same tumor, and the evaluation of stromal invasion was not possible by cytology.[1](#dc23844-bib-0001){ref-type="ref"}, [3](#dc23844-bib-0003){ref-type="ref"}, [11](#dc23844-bib-0011){ref-type="ref"} However, Kushima studied scrape or imprint cytology for intraoperative consultation in 6 cases that were under‐diagnoses from the histological evaluation of frozen sections.[11](#dc23844-bib-0011){ref-type="ref"} Among them, 3 cases (3/6, 50%) were diagnosed as borderline tumors by cytology and 2 of the 3 cases had a borderline area \>30%.[11](#dc23844-bib-0011){ref-type="ref"} His study suggested that borderline tumors could be more accurately diagnosed by intraoperative cytology when the borderline malignant areas are a main component of the tumor. In the recently published WHO report, the classification of ovarian tumors now includes a seromucinous borderline tumor.[12](#dc23844-bib-0012){ref-type="ref"} The seromucinous borderline tumor can be subdivided into endocervical‐type mucinous borderline tumor, and mixed‐epithelial papillary cystadenomas of borderline malignancy of Mullerian type. The squamous dominance of mixed‐epithelial papillary cystadenomas of borderline malignancy of Mullerian type was described by Nagai et al. and two of the authors of the present study (D.O. and T.M) were the co‐authors of that article.[16](#dc23844-bib-0016){ref-type="ref"} According to our experience with mixed‐epithelial papillary cystadenomas of borderline malignancy of Mullerian type, we performed the first trial of intraoperative cytology diagnosis of seromucinous borderline tumors in the present study. Subsequently, endocervical‐type mucinous borderline tumors were under‐diagnosed, and a mixed‐epithelial papillary cystadenomas of borderline malignancy of Mullerian type was over‐diagnosed. The present study involved a small number of cases of seromucinous borderline tumors. An intraoperative cytological study with a larger number of cases of seromucinous borderline tumors is needed to examine the application of cytology to borderline tumor diagnosis.

Michael et al. performed a comparative study of intraoperative cytology and frozen sections in 63 cases and reported that cytology was slightly better than frozen sections.[6](#dc23844-bib-0006){ref-type="ref"} In contrast, in the present study, the histological diagnosis of frozen sections was slightly better than that of cytology. This difference may have been due to the different methods used to obtain cytological materials. Michael et al. used a combination of imprint cytology (40 cases), fine‐needle aspiration cytology (38 cases), and scrapes (5 cases).[6](#dc23844-bib-0006){ref-type="ref"} FNAC and scrapes are superior to imprints,[6](#dc23844-bib-0006){ref-type="ref"} and this combination of methods may have led to their conclusion that cytology was better than frozen sections.

The comparison of intraoperative cytology and frozen sections in the present study indicates that imprint cytology is superior to frozen sections in diagnosing the histological types of carcinoma, such as clear cell carcinoma and mixed carcinoma. Overall, nearly 85% of malignant ovarian tumors are epithelial,[1](#dc23844-bib-0001){ref-type="ref"} which contributes to the superiority of imprint cytology for the diagnosis of these tumors.

In conclusion, the useful aspects of imprint cytology in intraoperative consultation are the diagnosis of benignity or malignancy and the accuracy of diagnosing clear cell carcinoma and mixed carcinoma. In contrast, imprint cytology is difficult to use for the diagnosis of seromucinous borderline tumors.
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